VALEANT PHARMA INTL VRX (NYSE) $ 19.91 Change: -0.05 -0.25% | Volume: 137,073
Sponsored by Click here!

VALEANT PHARMA - Fundamental Profile

Company Information

Ticker Symbol: VRX
Exchange: NYSE
Contact Info: One Enterprise Aliso Viejo CA 92656 949 461-6000
CEO/President: Timothy C. Tyson
Industry: Medical - Drugs / Standard Industry Code: 2834
Description: Valeant Pharmaceuticals International is a global, publicly traded, research-based specialty pharmaceutical company that discovers, develops, manufactures and markets a broad range of pharmaceutical products.

Share Information

Shares Outstanding: 88,070 (000) Market Value: 1,637,280 ($000)
Percentage of Inst.Shareholders: 98.94% Number of Inst.Shareholders: 8.30%
Last Quarter Sales: 168.42 ($Mil.) Last Quarter Net Income: 206.69 ($Mil.)
Last Quarter EPS: 0.11 P/E Ratio: 126
Most Recent Earnings: 0.11 on 11/06/08 Earnings Per Share: 1.41
Most Recent Split: 3-2 on 03/17/98 Annual Dividend Rate: 0
Most Recent Dividend: 0.078 on 08/15/06 Annual Dividend Yield: 0%
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
advertisement

Top Competitors

PFIZER INC -28.60 16.27
JOHNSON AND JOH -19.00 56.18
BRISTOL MYERS S -20.40 20.70
SCHERING PLOUGH -40.90 15.89
MERCK CO INC -57.80 25.00